Renovia Receives FDA OK for Next Generation Pelvic Digital Therapeutic

Renovia has received a nod from FDA for a next-generation pelvic digital therapeutic. The Boston-based company said the Ieva device is cleared for the strengthening of pelvic floor muscles and the treatment of stress, mixed, and mild to moderate urgency urinary incontinence (UI) in women. The next-generation leva Digital Therapeutic uses Renovia’s movement-based sensor and app technology to provide women real-time feedback as they perform their pelvic floor muscle exercises. The new leva Digital Therapeutic is based on the same mechanism of action and sensor technology found in current-generation leva Digital Therapeutic that has been shown to provide statistically significant improvement in objective pelvic floor muscle (PFM) performance measures, patient-reported UI symptom severity, and condition-specific quality of life. The clearance comes hot on the heels of the company’s completion of a multi-center, pilot randomized controlled trial (RCT) using the next-generation leva Digital Therapeutic device. The study included sixty (60) subjects, with the control group performing traditional Kegel exercises. The company said that despite being a 60-subject pilot study, the study found statistically better results among leva users. “We look forward to announcing and publishing the results of our pilot RCT in the coming months,” noted Samantha Pulliam, MD, CMO at Renovia. “In the meantime, we...
Source: MDDI - Category: Medical Devices Authors: Tags: Regulatory and Compliance Source Type: news

Related Links:

AIM: To estimate the economic burden of common health problems associated with pregnancy and childbirth, such as incontinence, mental health problems, or gestational diabetes, excluding acute complications of labour or birth, or severe acute adverse matern...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
No abstract available
Source: American Journal of Physical Medicine and Rehabilitation - Category: Rehabilitation Tags: Evidence-Based Physiatry: Cochrane Corner Source Type: research
We describe Per Anal Endoscopic Rectopexy (PAER), a new treatment for complete rectal prolapse, which involves fixing the anterior rectal wall to the under-surface of the anterior abdominal wall and posterior rectal wall to the sacrum, through a submucosal tunnel (both endoluminally). This is a prospective single-centre pilot study done at a tertiary care centre. A total of 12 patients with a mean age of 48  years underwent the procedure. Constipation and incontinence were present in 8 and 4 patients, respectively and a significant improvement was seen in both following the procedure. A significant decrease in anorect...
Source: Indian Journal of Gastroenterology - Category: Gastroenterology Source Type: research
CONCLUSION: PROMs are reliable predictors of maximal treatment in patients with FI and can be readily used in primary care to aid surgical referrals and can be applied in hospital settings as an aid to guide surgical treatment decisions. PMID: 31937071 [PubMed]
Source: Annals of Coloproctology - Category: Gastroenterology Tags: Ann Coloproctol Source Type: research
Authors: Kim CN PMID: 31937067 [PubMed]
Source: Annals of Coloproctology - Category: Gastroenterology Tags: Ann Coloproctol Source Type: research
ConclusionThe autologous fascial wrap technique is efficient and easy to harvest, with comparable clinical outcomes to other techniques. The medium-term results have been encouraging, but longer-term follow up is needed.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
We report a patient with relapsing-remitting multiple sclerosis, who developed rheumatoid arthritis after exposure to natalizumab. While some multiple sclerosis therapies are known to unmask autoimmune conditions, natalizumab is rarely implicated as a cause of alternative autoimmunity. This case illustrates an unusual clinical scenario which may support recent scientific work suggesting that when natalizumab blocks T helper 1 cells from entering the central nervous system, T helper 17 cells may continue to migrate into immune-privileged spaces and cause pathologic inflammation.Brief Background: Multiple sclerosis (MS) pati...
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Urinary incontinence (UI) is highly prevalent and affects the lives of many men and women. We aimed to conduct a qualitative evidence synthesis (QES) to explore the experience of living with UI and to develop ...
Source: BMC Urology - Category: Urology & Nephrology Authors: Tags: Research article Source Type: research
;rez López Sánchez There is a high prevalence of comorbidities among patients with chronic obstructive pulmonary disease (COPD). Comorbidities are likely common in patients with any COPD degree and are associated with increased mortality. The aim of this study was to determine the prevalence of thirty-one different COPD comorbidities and to evaluate the association between physical activity (PA) levels in people with COPD residing in Spain. Cross-sectional data from the Spanish National Health Survey 2017 were analysed. A total of 601 adults (52.2% females) with COPD aged 15 to 69 participated in this ...
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
Fecal incontinence frequently occurs after total mesorectal excision for rectal cancer. This prospective study analyzed predictive factors and the impact of pelvic intraoperative neuromonitoring at different f...
Source: World Journal of Surgical Oncology - Category: Cancer & Oncology Authors: Tags: Research Source Type: research
More News: Incontinence | Medical Devices | Statistics | Study | Women